Drug Shortage Report for CEFTRIAXONE FOR INJECTION
Report ID | 143328 |
Drug Identification Number | 02409968 |
Brand name | CEFTRIAXONE FOR INJECTION |
Common or Proper name | CefTRIAXone for Injection 100 g SmartPak® |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | CEFTRIAXONE |
Strength(s) | 100G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | SmartPak |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-11-01 |
Actual start date | 2021-11-01 |
Estimated end date | 2021-12-21 |
Actual end date | 2021-12-21 |
Shortage status | Resolved |
Updated date | 2021-12-30 |
Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays we will be extending the backorder on our CefTRIAXone for Injection 100 g SmartPak®. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2021-12-30 | French | Compare |
v15 | 2021-12-30 | English | Compare |
v14 | 2021-12-17 | French | Compare |
v13 | 2021-12-17 | English | Compare |
v12 | 2021-11-24 | French | Compare |
v11 | 2021-11-24 | English | Compare |
v10 | 2021-11-02 | English | Compare |
v9 | 2021-10-27 | French | Compare |
v8 | 2021-10-27 | English | Compare |
v7 | 2021-10-27 | French | Compare |
v6 | 2021-10-27 | English | Compare |
v5 | 2021-08-31 | French | Compare |
v4 | 2021-08-31 | English | Compare |
v3 | 2021-08-02 | English | Compare |
v2 | 2021-07-30 | French | Compare |
v1 | 2021-07-30 | English | Compare |
Showing 1 to 16 of 16